실시간
Clinical OMICsPost-Stroke Arm Immobility Improved with Spinal Cord StimulationClinical OMICsInfant Brain Development Sheds Light on Parkinson’s Link with AutismClinical OMICsAlzheimer’s Genetic Risk Loci: 16 New CandidatesEndpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meetingEndpoints NewsDimension seeks up to $750M for third life sciences fund after string of successEndpoints NewsElevance talks 'practical' AIEndpoints NewsMammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once againFierceBiotechAutobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2BioWorldAppointments and advancements for June 4, 2026BioWorldFinancings for June 4, 2026BioWorldIn the clinic for June 4, 2026BioWorldOther news to note for June 4, 2026
FierceBiotech 2026년 4월 20일

AstraZeneca’s faith in IL-33 inhibitor continues to pay off with latest phase 3 COPD win

AstraZeneca’s faith in IL-33 inhibitor continues to pay off with latest phase 3 COPD win

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.